Home » Stocks » NTRB

Nutriband Inc. (NTRB)

Stock Price: $12.50 USD 0.00 (0.00%)
Updated Jan 15, 2021 9:30 AM EST - Market closed
Market Cap 76.58M
Revenue (ttm) 615,188
Net Income (ttm) -1.63M
Shares Out 5.65M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE 250.00
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $12.50
Previous Close $12.50
Change ($) 0.00
Change (%) 0.00%
Day's Open 12.50
Day's Range 12.50 - 12.50
Day's Volume 0
52-Week Range 6.02 - 19.74

News

There are no news available yet.

About NTRB

Nutriband develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patc... [Read more...]

Industry
Biotechnology
Stock Exchange
OTCMKTS
Ticker Symbol
NTRB
Full Company Profile

Financial Performance

In 2019, Nutriband's revenue was $370,647, an increase of 51.11% compared to the previous year's $245,285. Losses were -$2.72 million, -18.30% less than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Nutriband is 24.00, which is an increase of 92.00% from the latest price.

Price Target
$24.00
(92.00% upside)